Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Changes After Major Joint Replacement (Cognigram)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02964221
Recruitment Status : Completed
First Posted : November 16, 2016
Last Update Posted : May 10, 2017
Sponsor:
Information provided by (Responsible Party):
Dr. Stephen Choi, Sunnybrook Health Sciences Centre

Brief Summary:
Patients assume that cognitive performance rapidly returns to baseline after anesthesia and surgery. Several studies have shown that one week after major non-cardiac surgery about 27% of patients have postoperative cognitive dysfunction (POCD) and 10% of patients at 3 months. Very few studies have assessed the incidence of POCD beyond 3 months. POCD significantly reduces quality of life. Identifying risk factors for POCD is important because it is associated with prolonged hospital stay, loss of independence, and premature retirement. There is an urgent need to measure and document the level of cognitive change associated with surgery with an easy to use tool, both prior to admission and after discharge. This information can be used to plan appropriate care paths and to identify or test the efficacy of potential new treatments to alter the negative trajectory.

Condition or disease Intervention/treatment
Postoperative Cognitive Dysfunction Mild Cognitive Impairment Delirium Cognitive Deficit Cognitive Change Working Memory Other: Cognitive Testing

Detailed Description:

Postoperative cognitive dysfunction (POCD) is thought to affect a significant proportion of patients after major surgery (up to 10% at 3 months). This is potentially a major public health issue because patients with POCD have prolonged hospital admission, loss of independence and mortality. Undoubtedly, if POCD is as prevalent and devastating as has been previously reported, the decision to undergo elective surgery should be influenced by the risk of developing POCD. Given the scope of the issue, the deficiencies in the literature surrounding POCD are concerning. There are many methodological issues with previous studies and the diagnosis of POCD in the perioperative period.

It is imperative that the true natures of postoperative cognitive changes are elucidated so that preoperative risk stratification can be appropriately determined. This will lead to care pathways and interventions that can modify any possible downward changes thereby reducing the negative impact on patients and the health care system.

Study Hypothesis: The incidence of postoperative cognitive changes in the joint arthroplasty population is influenced by postoperative complications, pre-existing mild cognitive impairment, and pre-existing comorbid conditions.

Study Objectives:

  1. To conduct a pilot study for six to 12 months to assess both the rate of recruitment (goal of 15 participants/month) and postoperative in-person follow-up (at 6 weeks and 4.5 months), and determine if a large-scale study of 600 participants is feasible
  2. To determine the sensitivity and accuracy of Cognigram (CogState Brief Battery - CBB) for detecting changes in cognitive function during the perioperative period
  3. To determine whether pre-existing mild cognitive impairment (MCI), preoperative chronic inflammatory states, and acute postoperative complications affect changes in postoperative cognitive function

Layout table for study information
Study Type : Observational
Actual Enrollment : 90 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Assessing Postoperative Cognitive Changes After Major Joint Arthroplasty: A Feasibility Study Using the CogState Brief Battery
Actual Study Start Date : June 15, 2016
Actual Primary Completion Date : May 1, 2017
Actual Study Completion Date : May 1, 2017

Intervention Details:
  • Other: Cognitive Testing
    Computerized CogState Brief Battery (CBB), Cognigram, assesses changes in four cognitive domains including psychomotor function, attention, learning and memory, and working memory. The CBB is a computerized test based on card games that can be administered online. .


Primary Outcome Measures :
  1. Change in Cognitive Brief Battery (CBB) score from baseline to 4.5 months after surgery [ Time Frame: 4.5 months after surgery ]
    Change in Cognitive Brief Battery (CBB) score from baseline to 4.5 months after surgery


Secondary Outcome Measures :
  1. Proportion of patients developing severe cognitive dysfunction at 4.5 months after surgery (defined as CBB score less than 80) [ Time Frame: 4.5 months after surgery ]
    Proportion of patients developing severe cognitive dysfunction at 4.5 months after surgery (defined as CBB score less than 80)

  2. Proportion of patients developing mild cognitive impairment at 4.5 months after surgery defined as CBB score between 81 and 90 [ Time Frame: 4.5 months after surgery ]
    Proportion of patients developing mild cognitive impairment at 4.5 months after surgery defined as CBB score between 81 and 90

  3. The effect of pre-operative mild cognitive impairment, pre-operative chronic inflammatory states, postoperative delirium, and postoperative complications on the incidence of mild cognitive impairment and severe cognitive dysfunction at 4.5 months [ Time Frame: 4.5 months after surgery ]
    The effect of pre-operative mild cognitive impairment, pre-operative chronic inflammatory states, postoperative delirium, and postoperative complications on the incidence of mild cognitive impairment and severe cognitive dysfunction at 4.5 months



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing total hip arthroplasty (THA) or total knee arthroplasty (TKA) at the Holland Orthopedic and Arthritic Centre (HOAC) at Sunnybrook Health Sciences Centre (SHSC).
Criteria

Inclusion Criteria:

• All patients ≥ 50 years of age undergoing elective total hip or knee arthroplasty at Sunnybrook Health Sciences Centre

Exclusion Criteria:

  • Lack of informed consent
  • Inability to comply with study procedures or follow-up visits
  • Patients with diagnosed dementia or those being treated with donepezil (Aricept®)
  • Patients with severe cognitive impairment defined as baseline with a CBB score of equal to or less than 80 in at least one of the 4 CBB domains
  • Patients with psychiatric diagnoses including schizophrenia, bipolar disorder, major depressive mood disorder
  • Patients undergoing a second joint replacement & previously enrolled in this study within the past 6 months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02964221


Sponsors and Collaborators
Dr. Stephen Choi
Investigators
Layout table for investigator information
Principal Investigator: Stephen Choi, MD,FRCPC,MSc Sunnybrook Health Sciences Centre

Layout table for additonal information
Responsible Party: Dr. Stephen Choi, Assistant Professor, University of Toronto; Staff Anesthesiologist and Director of Clinical Research, Department of Anesthesia, Sunnybrook Health Sciences Centre, Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier: NCT02964221     History of Changes
Other Study ID Numbers: 045-2015
First Posted: November 16, 2016    Key Record Dates
Last Update Posted: May 10, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Additional relevant MeSH terms:
Layout table for MeSH terms
Cognitive Dysfunction
Delirium
Cognition Disorders
Neurocognitive Disorders
Mental Disorders
Confusion
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms